Review



pcag flp recombinase  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc pcag flp recombinase
    Pcag Flp Recombinase, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 34 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcag flp recombinase/product/Addgene inc
    Average 93 stars, based on 34 article reviews
    pcag flp recombinase - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    93
    Addgene inc pcag flp recombinase
    Pcag Flp Recombinase, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcag flp recombinase/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    pcag flp recombinase - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    94
    Addgene inc flp recombinase expressing vector pcag flpo
    (A) Diagram of engineered HEK 293 cell with a single-copy landing pad located in the AAVS1 safe harbor site. FRT, FRT3: <t>Flp-recombinase</t> target sites; NeoR: Neomycin Resistance Gene; HSV-TK: Herpes Simplex Virus (HSV) thymidine kinase (TK); eGFP: enhanced Green Fluorescence Protein. (B) Left panel: Schematic diagram of repeatable AAVS1 site-specific integration of genetic payloads such as mNF-Cas13d gene circuit through Flp-recombinase-mediated cassette exchange (FLP-RMCE). Right panel: RMCE-based integration will result in a DNA construct switching between donor plasmid and target site. Successful integration of mNF-Cas13d gene circuit shifted the fluorescence signal from green (eGFP) to red (mCherry). HSV-TK in the donor plasmid backbone serves as a negative selection marker against random integration. (C) Diagram of synthetic mNF gene circuit for Dox-controlled tuning of co-expressed tetracycline repressor (TetR), mCherry reporter and Cas13d protein levels after site-specific integration. TetO: Tetracycline Operator; P2A: self-cleaving peptide. (D) Representative dose-responses of fluorescence intensity histograms from stably integrated mNF-Cas13d gene circuit measured at 0, 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 100 ng/ml Dox levels, respectively. (E) Dose-responses of mean fluorescence intensity of mCherry reporter for stably integrated mNF-Cas13d gene circuit in HEK 293 cells (n=3). (F) Dose-responses of coefficient of variation (CV) of mCherry reporter for stably integrated mNF-Cas13d gene circuit in HEK 293 cells (n=3).
    Flp Recombinase Expressing Vector Pcag Flpo, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/flp recombinase expressing vector pcag flpo/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    flp recombinase expressing vector pcag flpo - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    Addgene inc flp recombinase expression plasmid pcag flpe
    (A) Diagram of engineered HEK 293 cell with a single-copy landing pad located in the AAVS1 safe harbor site. FRT, FRT3: <t>Flp-recombinase</t> target sites; NeoR: Neomycin Resistance Gene; HSV-TK: Herpes Simplex Virus (HSV) thymidine kinase (TK); eGFP: enhanced Green Fluorescence Protein. (B) Left panel: Schematic diagram of repeatable AAVS1 site-specific integration of genetic payloads such as mNF-Cas13d gene circuit through Flp-recombinase-mediated cassette exchange (FLP-RMCE). Right panel: RMCE-based integration will result in a DNA construct switching between donor plasmid and target site. Successful integration of mNF-Cas13d gene circuit shifted the fluorescence signal from green (eGFP) to red (mCherry). HSV-TK in the donor plasmid backbone serves as a negative selection marker against random integration. (C) Diagram of synthetic mNF gene circuit for Dox-controlled tuning of co-expressed tetracycline repressor (TetR), mCherry reporter and Cas13d protein levels after site-specific integration. TetO: Tetracycline Operator; P2A: self-cleaving peptide. (D) Representative dose-responses of fluorescence intensity histograms from stably integrated mNF-Cas13d gene circuit measured at 0, 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 100 ng/ml Dox levels, respectively. (E) Dose-responses of mean fluorescence intensity of mCherry reporter for stably integrated mNF-Cas13d gene circuit in HEK 293 cells (n=3). (F) Dose-responses of coefficient of variation (CV) of mCherry reporter for stably integrated mNF-Cas13d gene circuit in HEK 293 cells (n=3).
    Flp Recombinase Expression Plasmid Pcag Flpe, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/flp recombinase expression plasmid pcag flpe/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    flp recombinase expression plasmid pcag flpe - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    94
    Addgene inc flp recombinase
    (A) Diagram of engineered HEK 293 cell with a single-copy landing pad located in the AAVS1 safe harbor site. FRT, FRT3: <t>Flp-recombinase</t> target sites; NeoR: Neomycin Resistance Gene; HSV-TK: Herpes Simplex Virus (HSV) thymidine kinase (TK); eGFP: enhanced Green Fluorescence Protein. (B) Left panel: Schematic diagram of repeatable AAVS1 site-specific integration of genetic payloads such as mNF-Cas13d gene circuit through Flp-recombinase-mediated cassette exchange (FLP-RMCE). Right panel: RMCE-based integration will result in a DNA construct switching between donor plasmid and target site. Successful integration of mNF-Cas13d gene circuit shifted the fluorescence signal from green (eGFP) to red (mCherry). HSV-TK in the donor plasmid backbone serves as a negative selection marker against random integration. (C) Diagram of synthetic mNF gene circuit for Dox-controlled tuning of co-expressed tetracycline repressor (TetR), mCherry reporter and Cas13d protein levels after site-specific integration. TetO: Tetracycline Operator; P2A: self-cleaving peptide. (D) Representative dose-responses of fluorescence intensity histograms from stably integrated mNF-Cas13d gene circuit measured at 0, 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 100 ng/ml Dox levels, respectively. (E) Dose-responses of mean fluorescence intensity of mCherry reporter for stably integrated mNF-Cas13d gene circuit in HEK 293 cells (n=3). (F) Dose-responses of coefficient of variation (CV) of mCherry reporter for stably integrated mNF-Cas13d gene circuit in HEK 293 cells (n=3).
    Flp Recombinase, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/flp recombinase/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    flp recombinase - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    Addgene inc flp recombinase flpe
    Figure 1. Overview of the design and dual-functionality of the TRE-Lox system. (a) Overall structure of the 5′ end of the murine cathepsin D (CatD) gene (CTSD) and its promoter region (PCTSD, dark gray), indicating the relative position of the two gRNAs (black arrows) used for CRISPR/Cas9- assisted homologous recombination. Note the placement of the TATA box (TATA) very close to the main transcription start site (TSS) (right-angle arrow), the presence of the initiation codon (ATG, dashed white line) within Exon 1 (Ex 1, light gray), and the presence of a splice donor (SD) and splice acceptor (SA) flanking Intron 1 (black line). (b) Structure of the TRE-Lox knock-in (KI) insert, illustrating the relative positions of the two tet-operons (tetO2, green) and one LoxP site (LoxP, light blue) within the 5′ untranslated region (5′UTR) and, within Intron 1, a tetracycline response element (TRE) comprised of seven tetO repeats (tetO7) and the second LoxP site. The relative placement of the puromycin resistance cassette (Puror, purple) flanked by two FRT sites (FRT, dark blue), which is excisable by Flp <t>recombinase,</t> is depicted using a curly bracket. (c) Downregulation of CTSD via the action of rtTRKRAB acting on the TRE-Lox insert. In the presence of Dox (red triangles), rtTRKRAB binds to the tetO repeats within both the 5′UTR and Intron 1, triggering methylation of histones in a radius of 2–3 kb, thereby remodeling the chromatin and silencing the CTSD gene. (d) Genetic deletion of CTSD via the action of Cre recombinase on the TRE-Lox insert. The figure depicts the end result of Cre-mediated recombination of the TRE-Lox KI insert, which causes removal of the initiation codon, the first portion of the coding region of Exon 1 encoding the signal peptide of CatD, and the 5′ end of Intron 1.
    Flp Recombinase Flpe, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/flp recombinase flpe/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    flp recombinase flpe - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    Image Search Results


    (A) Diagram of engineered HEK 293 cell with a single-copy landing pad located in the AAVS1 safe harbor site. FRT, FRT3: Flp-recombinase target sites; NeoR: Neomycin Resistance Gene; HSV-TK: Herpes Simplex Virus (HSV) thymidine kinase (TK); eGFP: enhanced Green Fluorescence Protein. (B) Left panel: Schematic diagram of repeatable AAVS1 site-specific integration of genetic payloads such as mNF-Cas13d gene circuit through Flp-recombinase-mediated cassette exchange (FLP-RMCE). Right panel: RMCE-based integration will result in a DNA construct switching between donor plasmid and target site. Successful integration of mNF-Cas13d gene circuit shifted the fluorescence signal from green (eGFP) to red (mCherry). HSV-TK in the donor plasmid backbone serves as a negative selection marker against random integration. (C) Diagram of synthetic mNF gene circuit for Dox-controlled tuning of co-expressed tetracycline repressor (TetR), mCherry reporter and Cas13d protein levels after site-specific integration. TetO: Tetracycline Operator; P2A: self-cleaving peptide. (D) Representative dose-responses of fluorescence intensity histograms from stably integrated mNF-Cas13d gene circuit measured at 0, 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 100 ng/ml Dox levels, respectively. (E) Dose-responses of mean fluorescence intensity of mCherry reporter for stably integrated mNF-Cas13d gene circuit in HEK 293 cells (n=3). (F) Dose-responses of coefficient of variation (CV) of mCherry reporter for stably integrated mNF-Cas13d gene circuit in HEK 293 cells (n=3).

    Journal: bioRxiv

    Article Title: Optimizing a CRISPR-Cas13d gene circuit for tunable target RNA downregulation with minimal collateral RNA cutting

    doi: 10.1101/2024.05.11.593702

    Figure Lengend Snippet: (A) Diagram of engineered HEK 293 cell with a single-copy landing pad located in the AAVS1 safe harbor site. FRT, FRT3: Flp-recombinase target sites; NeoR: Neomycin Resistance Gene; HSV-TK: Herpes Simplex Virus (HSV) thymidine kinase (TK); eGFP: enhanced Green Fluorescence Protein. (B) Left panel: Schematic diagram of repeatable AAVS1 site-specific integration of genetic payloads such as mNF-Cas13d gene circuit through Flp-recombinase-mediated cassette exchange (FLP-RMCE). Right panel: RMCE-based integration will result in a DNA construct switching between donor plasmid and target site. Successful integration of mNF-Cas13d gene circuit shifted the fluorescence signal from green (eGFP) to red (mCherry). HSV-TK in the donor plasmid backbone serves as a negative selection marker against random integration. (C) Diagram of synthetic mNF gene circuit for Dox-controlled tuning of co-expressed tetracycline repressor (TetR), mCherry reporter and Cas13d protein levels after site-specific integration. TetO: Tetracycline Operator; P2A: self-cleaving peptide. (D) Representative dose-responses of fluorescence intensity histograms from stably integrated mNF-Cas13d gene circuit measured at 0, 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 100 ng/ml Dox levels, respectively. (E) Dose-responses of mean fluorescence intensity of mCherry reporter for stably integrated mNF-Cas13d gene circuit in HEK 293 cells (n=3). (F) Dose-responses of coefficient of variation (CV) of mCherry reporter for stably integrated mNF-Cas13d gene circuit in HEK 293 cells (n=3).

    Article Snippet: The AAVS1-targeting eSpCas9 vector (Addgene #199213) was constructed in the previous study . the codon-optimized FLP recombinase expressing vector- pCAG-Flpo also available as Addgene plasmid 60662 was a gift from Dr. Massimo Scanziani.

    Techniques: Virus, Fluorescence, Construct, Plasmid Preparation, Selection, Marker, Stable Transfection

    Figure 1. Overview of the design and dual-functionality of the TRE-Lox system. (a) Overall structure of the 5′ end of the murine cathepsin D (CatD) gene (CTSD) and its promoter region (PCTSD, dark gray), indicating the relative position of the two gRNAs (black arrows) used for CRISPR/Cas9- assisted homologous recombination. Note the placement of the TATA box (TATA) very close to the main transcription start site (TSS) (right-angle arrow), the presence of the initiation codon (ATG, dashed white line) within Exon 1 (Ex 1, light gray), and the presence of a splice donor (SD) and splice acceptor (SA) flanking Intron 1 (black line). (b) Structure of the TRE-Lox knock-in (KI) insert, illustrating the relative positions of the two tet-operons (tetO2, green) and one LoxP site (LoxP, light blue) within the 5′ untranslated region (5′UTR) and, within Intron 1, a tetracycline response element (TRE) comprised of seven tetO repeats (tetO7) and the second LoxP site. The relative placement of the puromycin resistance cassette (Puror, purple) flanked by two FRT sites (FRT, dark blue), which is excisable by Flp recombinase, is depicted using a curly bracket. (c) Downregulation of CTSD via the action of rtTRKRAB acting on the TRE-Lox insert. In the presence of Dox (red triangles), rtTRKRAB binds to the tetO repeats within both the 5′UTR and Intron 1, triggering methylation of histones in a radius of 2–3 kb, thereby remodeling the chromatin and silencing the CTSD gene. (d) Genetic deletion of CTSD via the action of Cre recombinase on the TRE-Lox insert. The figure depicts the end result of Cre-mediated recombination of the TRE-Lox KI insert, which causes removal of the initiation codon, the first portion of the coding region of Exon 1 encoding the signal peptide of CatD, and the 5′ end of Intron 1.

    Journal: International journal of molecular sciences

    Article Title: A Dual-Function "TRE-Lox" System for Genetic Deletion or Reversible, Titratable, and Near-Complete Downregulation of Cathepsin D.

    doi: 10.3390/ijms24076745

    Figure Lengend Snippet: Figure 1. Overview of the design and dual-functionality of the TRE-Lox system. (a) Overall structure of the 5′ end of the murine cathepsin D (CatD) gene (CTSD) and its promoter region (PCTSD, dark gray), indicating the relative position of the two gRNAs (black arrows) used for CRISPR/Cas9- assisted homologous recombination. Note the placement of the TATA box (TATA) very close to the main transcription start site (TSS) (right-angle arrow), the presence of the initiation codon (ATG, dashed white line) within Exon 1 (Ex 1, light gray), and the presence of a splice donor (SD) and splice acceptor (SA) flanking Intron 1 (black line). (b) Structure of the TRE-Lox knock-in (KI) insert, illustrating the relative positions of the two tet-operons (tetO2, green) and one LoxP site (LoxP, light blue) within the 5′ untranslated region (5′UTR) and, within Intron 1, a tetracycline response element (TRE) comprised of seven tetO repeats (tetO7) and the second LoxP site. The relative placement of the puromycin resistance cassette (Puror, purple) flanked by two FRT sites (FRT, dark blue), which is excisable by Flp recombinase, is depicted using a curly bracket. (c) Downregulation of CTSD via the action of rtTRKRAB acting on the TRE-Lox insert. In the presence of Dox (red triangles), rtTRKRAB binds to the tetO repeats within both the 5′UTR and Intron 1, triggering methylation of histones in a radius of 2–3 kb, thereby remodeling the chromatin and silencing the CTSD gene. (d) Genetic deletion of CTSD via the action of Cre recombinase on the TRE-Lox insert. The figure depicts the end result of Cre-mediated recombination of the TRE-Lox KI insert, which causes removal of the initiation codon, the first portion of the coding region of Exon 1 encoding the signal peptide of CatD, and the 5′ end of Intron 1.

    Article Snippet: To remove the FRT-flanked puromycin resistance cassette, TL1C8 cells were subsequently transfected with an enhanced form of Flp recombinase (Flpe) fused with GFP (pCAG-Flpe:GFP; Addgene plasmid #13788 [33]), and pools of Flpe (and GFP-only control)transfected cells were isolated by FACS.

    Techniques: CRISPR, Homologous Recombination, Knock-In, Methylation

    Figure 2. Development and characterization of TRE-Lox KI cell lines targeting the endogenous CTSD gene of mouse embryonic fibroblasts (MEFs). (a) Overview of the genotyping strategy, including the relative position of different primers (blue arrows) and the predicted sizes of different PCR amplicons (black boxes) used to distinguish different possible outcomes of insertion of the TRE-Lox construct via Cas9-assisted homologous recombination. The main possibilities include (but are not limited to) the following: (1) the unmodified endogenous murine CTSD allele (top); (2) insertion of the TRE-Lox KI insert as designed (middle); and (3) nonhomologous DNA end joining (NHEJ) resulting (in this case) in the excision of the segment of DNA between gRNA1 and gRNA2 (bottom, see Supplementary Materials Figure S1). (b) Genotyping of a subset of clones obtained after selection of individual puromycin-resistant clonal lines. The two bands within clone 1C8 (referred to as TL1C8) were excised, sequenced, and confirmed to be amplified from one allele carrying the TRE-Lox KI insert (upper band) and another allele featuring NHEJ, which results in functional knock-out (KO) of CTSD (sequences provided in Supplementary Materials Figure S5a–c). (c) CatD proteolytic activity in wild-type MEFs, or TL1C8 cells transiently transfected with empty vector (yellow), GFP (green) or Flp recombinase (dark blue). Note the low level of CatD activity in TL1C8 cells, which is reversed by transfection with Flp recombinase, resulting in activity close to the expected value of 50% of wild-type MEFs (gray dotted line). (d) CatD activity in several clonal lines of TL1C8-Flp cells stably expressing rtTRKRAB incubated for 4 d in the absence or presence of Dox (100 ng/mL). Note how, in the absence of Dox (white columns), all tested clones harbor CatD activity that is very close to 50% of the levels within MEFs (gray dotted line), as expected, whereas in the presence of Dox (gray columns), CatD activity is greatly decreased. Data in (c,d) are mean ± SEM of 4 replicates. * p < 0.05; ns = nonsignificant.

    Journal: International journal of molecular sciences

    Article Title: A Dual-Function "TRE-Lox" System for Genetic Deletion or Reversible, Titratable, and Near-Complete Downregulation of Cathepsin D.

    doi: 10.3390/ijms24076745

    Figure Lengend Snippet: Figure 2. Development and characterization of TRE-Lox KI cell lines targeting the endogenous CTSD gene of mouse embryonic fibroblasts (MEFs). (a) Overview of the genotyping strategy, including the relative position of different primers (blue arrows) and the predicted sizes of different PCR amplicons (black boxes) used to distinguish different possible outcomes of insertion of the TRE-Lox construct via Cas9-assisted homologous recombination. The main possibilities include (but are not limited to) the following: (1) the unmodified endogenous murine CTSD allele (top); (2) insertion of the TRE-Lox KI insert as designed (middle); and (3) nonhomologous DNA end joining (NHEJ) resulting (in this case) in the excision of the segment of DNA between gRNA1 and gRNA2 (bottom, see Supplementary Materials Figure S1). (b) Genotyping of a subset of clones obtained after selection of individual puromycin-resistant clonal lines. The two bands within clone 1C8 (referred to as TL1C8) were excised, sequenced, and confirmed to be amplified from one allele carrying the TRE-Lox KI insert (upper band) and another allele featuring NHEJ, which results in functional knock-out (KO) of CTSD (sequences provided in Supplementary Materials Figure S5a–c). (c) CatD proteolytic activity in wild-type MEFs, or TL1C8 cells transiently transfected with empty vector (yellow), GFP (green) or Flp recombinase (dark blue). Note the low level of CatD activity in TL1C8 cells, which is reversed by transfection with Flp recombinase, resulting in activity close to the expected value of 50% of wild-type MEFs (gray dotted line). (d) CatD activity in several clonal lines of TL1C8-Flp cells stably expressing rtTRKRAB incubated for 4 d in the absence or presence of Dox (100 ng/mL). Note how, in the absence of Dox (white columns), all tested clones harbor CatD activity that is very close to 50% of the levels within MEFs (gray dotted line), as expected, whereas in the presence of Dox (gray columns), CatD activity is greatly decreased. Data in (c,d) are mean ± SEM of 4 replicates. * p < 0.05; ns = nonsignificant.

    Article Snippet: To remove the FRT-flanked puromycin resistance cassette, TL1C8 cells were subsequently transfected with an enhanced form of Flp recombinase (Flpe) fused with GFP (pCAG-Flpe:GFP; Addgene plasmid #13788 [33]), and pools of Flpe (and GFP-only control)transfected cells were isolated by FACS.

    Techniques: Construct, Homologous Recombination, Clone Assay, Selection, Functional Assay, Knock-Out, Activity Assay, Transfection, Plasmid Preparation, Stable Transfection, Expressing, Incubation

    Figure 4. Functional and genotypic characterization of Cre-mediated genetic deletion of CatD made possible by the TRE-Lox system. (a) CatD activity in TL1C8-Flp cells transiently transfected with either GFP only (CTL, dark blue) or GFP-tagged Cre recombinase (Cre, green). Note that these are pools of GFP-positive cells selected by cell sorting 2 d after transfection. Data are mean ± SEM, n = 4,

    Journal: International journal of molecular sciences

    Article Title: A Dual-Function "TRE-Lox" System for Genetic Deletion or Reversible, Titratable, and Near-Complete Downregulation of Cathepsin D.

    doi: 10.3390/ijms24076745

    Figure Lengend Snippet: Figure 4. Functional and genotypic characterization of Cre-mediated genetic deletion of CatD made possible by the TRE-Lox system. (a) CatD activity in TL1C8-Flp cells transiently transfected with either GFP only (CTL, dark blue) or GFP-tagged Cre recombinase (Cre, green). Note that these are pools of GFP-positive cells selected by cell sorting 2 d after transfection. Data are mean ± SEM, n = 4,

    Article Snippet: To remove the FRT-flanked puromycin resistance cassette, TL1C8 cells were subsequently transfected with an enhanced form of Flp recombinase (Flpe) fused with GFP (pCAG-Flpe:GFP; Addgene plasmid #13788 [33]), and pools of Flpe (and GFP-only control)transfected cells were isolated by FACS.

    Techniques: Functional Assay, Activity Assay, Transfection, FACS